LBT 6.67% 1.4¢ lbt innovations limited

Ann: Presentation at 14th Bioshares Biotech Summit, page-9

  1. 216 Posts.
    lightbulb Created with Sketch. 32
    Being a Medical Scientist myself and experiencing the ever-changing world of Pathology and diagnostic testing, LBT is part of this advancing field of pathology. Microbiology is one of the last areas to embrace automation. When LBT begins selling these analysers the world of Microbiology will change forever. The ageing population and increased resistance to antibiotics means an increase in the demand for diagnostic testing and quicker turnaround times.
    Simply put, pathology (especially microbiology) needs to embrace innovation and change, otherwise the ever increasing demand and pressure for quicker and more accurate diagnostic testing will NEVER be met if we don't embrace this essential change. The future of Pathology depends on keeping up and ahead of technology.
    LBT is revolutionising microbiology! The demand for automation and increased diagnostic testing is only going to increase in the future! A win win for LBT.
 
watchlist Created with Sketch. Add LBT (ASX) to my watchlist
(20min delay)
Last
1.4¢
Change
-0.001(6.67%)
Mkt cap ! $21.91M
Open High Low Value Volume
1.5¢ 1.5¢ 1.4¢ $5.227K 372.6K

Buyers (Bids)

No. Vol. Price($)
1 227027 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 25750 1
View Market Depth
Last trade - 15.06pm 18/07/2024 (20 minute delay) ?
LBT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.